IHL 0.00% 4.1¢ incannex healthcare limited

That's it, just got to be patient."Thank you for reaching out to...

  1. 386 Posts.
    lightbulb Created with Sketch. 137
    That's it, just got to be patient.

    "Thank you for reaching out to us to discuss the possibility of working with Clarion Clinics. We appreciate your interest in the Clarion psychedelic-assisted therapy program as part of your treatment, and look forward to exploring whether this treatment option is suitable for you.

    Psychedelic-assisted therapy is an emerging field that has shown promising results for many people in clinical trials, when administered in a controlled and supportive environment by trained and experienced therapists.

    As you may be aware, the use of MDMA-assisted therapy for PTSD and psilocybin-assisted therapy for treatment-resistant depression was made possible as a service in Australia on 1st of July 2023, by the Australia’s pharmaceutical regulator, the TGA. In line with the TGA guidelines, Clarion is currently going through the process of approvals under the Authorised Prescriber Scheme, alongside the development of our first purpose-built clinic in Abbotsford, Victoria. While we anticipate no substantial delays, we must ensure all approvals and resources are in place before we commence any treatments.

    Registering for treatment with Clarion

    We have received your initial information, and so for the time being, you don’t need to do anything further. We have reserved your place on our waitlist, and we will be in touch once we have attained all the required approvals, and can commence screening.

    Before proceeding with treatment, it will be essential for the clinical team at Clarion to ensure that this treatment approach is safe and suitable for you. While psychedelic-assisted therapy can be beneficial for many people, it may not be suitable for everyone.

    Once we receive approval, our process will be as follows:

    Eligibility Process

    1. Initial Questionnaire

    Our initial screening step involves a comprehensive online questionnaire. This information is required to determine whether all inclusion criteria and no exclusion criteria are met. We will inform you of the outcome of this process, and whether you can proceed to the in-person screening visit.

    2. Meeting With Our Psychiatrist

    In order to be eligible for treatment, one of our psychiatrists will need to confirm your psychiatric diagnosis and assess your safety and suitability for this treatment. This initial consultation may be in person or via telehealth, and will include questions about your mental health, current medications, your personal circumstances, and your history. The session will last approximately one hour.

    3. Physical Check Up

    Before we commence treatment, it’s vital that you undergo a health assessment to ensure that you don’t have any medical issues that may be contraindicated for this class of treatment. The assessment will be conducted at our clinic by our practice nurse, will involve a blood draw, measurement of vital signs like blood pressure, and should take approximately 45 minutes to complete. We would typically schedule this in during the same visit as the psychiatric appointment.

    4. Suitability and Foundations

    The final stage of screening overlaps with the commencement of your treatment journey with your two treating psychedelic-assisted therapists (sometimes referred to as a “dyad”). Over one or two sessions, your therapy team will get to know you, explore some of the key foundations of the treatment approach, and also determine whether psychedelic-assisted therapy is the right treatment option for you at this time.

    Once all the eligibility and suitability screening is complete, we will confirm a treatment schedule which suits you, and commence treatment. Our standard treatment model will include an approximately 9-month program of care, which includes psychotherapy sessions with your treating dyad, all-day drug-assisted or “dosing” sessions, and also a program of group-based and adjunctive therapies. Further information about the treatment approach will be shared with you during the screening process.

    Please note, all steps in the eligibility and suitability screening process will be bulk-billed and there is no out-of-pocket expense to you. If you are accepted into the full treatment program, there will be a fee incurred for treatment.


    Once again, thank you for your expression of interest in treatment at Clarion, and we will be in touch in the near future to confirm your interest and start the screening process.

    Warm Regards,

    The Clarion Team

    www.clarionclinics.com "

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.